Loading clinical trials...
Loading clinical trials...
Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothor...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CytoSorbents, Inc
NCT07217899 · Blood Loss, Surgical, Blood Loss, Postoperative, and more
NCT01731444 · Blood Loss, Surgical
NCT06601582 · Cardiovascular Surgery, Blood Loss, Surgical
NCT06428682 · Breast Cancer, Blood Loss, Surgical
NCT05397652 · Rotator Cuff Tears, Hemorrhage, Surgical, and more
University of California, Davis Medical Center
Sacramento, California
University of Colorado
Denver, Colorado
Yale University
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions